Decentralised Crypto & Blockchain Search

ARDX
No result!
Bing Search Results
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative first-in-class medicines to improve treatment for people with ...
5800 Lake Wright Drive, Suite 301 Norfolk, VA 23502; P: 757.410.7704 | F: 866.726.2485; E: info@ardx.net
Ardelyx NASDAQ Updated Dec 3, 2021 12:09 AM. ARDX 1.70 0.47 (38.21%). Post-Market 0.24 (14.12%)
ARDX | Complete Ardelyx Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
And so to Ardelyx (ARDX). Shares were scraping the bottom in Tuesday’s trading with a massive 74% drop after the company announced it had received a letter from the FDA which suggests approval ...
Founded in 2006, ARDX is a Virginia-based corporation that has undergone significant growth as a SBA 8(m), SDB, and SWaM certified company. ARDX is on the GSA PSS (MOBIS) and GSA 8(a) STARS II Schedules, SPARC SB Prime IDIQ: Small, 8(a) and Woman-owned pools, SAMHSA IDIQ, and SeaPort-e vehicles. Mission
Ardelyx Inc. [ARDX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 34.62. With this latest performance, ARDX shares gained by 1.65% in over the last four-week period, additionally sinking by -82.12% over the last 6 months – not to mention a drop of -79.93% in the past year of trading.
ARDX currently public float of 75.14M and currently shorts hold a 7.84% ratio of that float. Today, the average trading volume of ARDX was 3.27M shares. ARDX’s Market Performance. ARDX stocks went up by 22.38% for the week, with a monthly drop of -5.79% and a quarterly performance of -19.15%, while its annual performance rate touched -81.90%.
From discovery through commercialization, all of us at Ardelyx ® are driven to advance patient care with targeted, first-in-class, novel mechanism therapies that address significant unmet medical needs. We developed a unique and innovative platform that enabled the discovery of new biological mechanisms and pathways to create targeted, first-in-class, oral, small molecule therapies.
Leveraging our scientific insights and discovery of the primary pathway of phosphate absorption, we have developed tenapanor for the treatment hyperphosphatemia, an electrolyte disorder in which there is an elevated level of phosphate in the blood. Hyperphosphatemia is a nearly universal condition in more than 550,000 Americans with chronic kidney disease (CKD) on dialysis, and a major risk ...
ARDX: About This Kit The overall goal of this kit is fun. Beyond this, the aim is to get you comfortable using a wide range of electronic components through small, simple and easy circuits. The focus is to get each circuit working then giving you the tools to figure out why.
546,000 results